NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Claude for Teachers Pressures EdTech: Stride Stock Tumbles on AI Competition

The free AI platform for K-12 educators raises new competitive concerns for the online education provider.

Claude for Teachers Pressures EdTech: Stride Stock Tumbles on AI Competition
Credit: Anthropic
Already have an account? Sign in.
07/14/2026 · 12:06 PM
LRN
/ Don’t stop at just one post.

Related↓

Stride Plunges After Losing Major Texas Virtual School Contract
06/15/2026 · 2:52 PM

Stride Plunges After Losing Major Texas Virtual School Contract

Stride shares plunged after Texas' Roscoe ISD decided not to renew its contract for Lone Star Online Academy, representing ~5% of 2025 enrollment. BMO highlights retention risks.

/ Subscriber only
/ Read more

Feed↓

FDA Approves First SMA Drug That Targets Muscle Loss, Not Just Nerves
Featured/ 09/11/2026 · 5:55 PM

FDA Approves First SMA Drug That Targets Muscle Loss, Not Just Nerves

The FDA approved Scholar Rock’s Isembyld, the first SMA therapy aimed at muscle wasting in patients already on nerve-targeted treatment.

/ Subscriber only
AstraZeneca’s Etcamah Combination Falls Short of Statistical Significance in SERENA-4
Featured/ 09/11/2026 · 4:48 PM

AstraZeneca’s Etcamah Combination Falls Short of Statistical Significance in SERENA-4

The Phase III SERENA-4 trial did not meet its primary PFS endpoint in untreated advanced ER-positive, HER2-negative breast cancer, despite a numerical benefit.

/ Subscriber only
Citi Says AppLovin Is Positioned to Meet or Beat Q3 Guidance
09/11/2026 · 4:30 PM

Citi Says AppLovin Is Positioned to Meet or Beat Q3 Guidance

Citi added a 90-day upside view on AppLovin with a $600 target, calling Q3 concerns misguided.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe